Indications for Liver Biopsy
Liver biopsy should be performed when clinically important information about diagnosis, prognosis, or treatment decisions cannot be obtained through safer non-invasive methods, and when the information gained will directly impact patient management. 1
Core Indications
The British Society of Gastroenterology (2020) identifies eight primary purposes for liver biopsy 1:
Diagnostic Purposes
- Clarify diagnosis when serological, biochemical, and imaging studies are inconclusive 1
- Establish diagnosis in acute and chronic hepatitis, cholestatic disorders, fatty liver disease, vascular diseases, infiltrative or storage diseases, infectious and granulomatous diseases 2
- Diagnose overlap syndromes when multiple liver pathologies coexist 2
- Confirm hepatocellular carcinoma in non-cirrhotic livers, where imaging specificity is reduced compared to cirrhotic livers 3
Prognostic Assessment
- Determine severity of liver damage through grading (inflammatory activity) and staging (extent of fibrosis) 1, 4
- Assess prognosis in patients with known diagnoses 1
- Evaluate disease progression or response to treatment 1
Therapeutic Decision-Making
- Guide treatment decisions when histological information will alter management 2, 1
- Monitor for hepatotoxicity during drug therapy 5
- Evaluate liver transplant allograft status 5
Lesion Characterization
- Diagnose specific abnormalities seen on cross-sectional imaging using targeted biopsy 1
- Determine the nature and/or grade of tumors 1
- Differentiate cholangiocarcinoma (which shows minimal vascular enhancement and cytokeratin 19 positivity) from other solid liver lesions 3
- Characterize hypervascular metastases that mimic benign lesions 3
Evolving Indications: Shift from Viral Hepatitis to Metabolic Disease
The indication landscape has dramatically shifted from hepatitis C virus (HCV) evaluation to metabolic dysfunction-associated fatty liver disease (MAFLD) assessment 6. A 2022 study demonstrated that HCV-related biopsies decreased substantially while MAFLD-related procedures progressively increased over a 5-year period 6.
Critical Justification Criteria
A liver biopsy for clinical purposes can be justified ONLY when ALL of the following conditions are met 1:
- The information gained is of value for patient management 1
- The patient is fully informed about indications, risks, benefits, alternatives, and follow-up plans and has provided informed consent 1
- The procedure is performed as safely as practicable 1
- The operator is competent to perform the technique 1
- The samples are of adequate quality and size (at least 20 mm length with 16G needle for percutaneous approach) 1
- The biopsy is examined by a sufficiently competent histopathologist 1
When Biopsy Is NOT Indicated
Non-invasive methods are preferred when virological, biochemical, serological, and imaging investigations can provide sufficient diagnostic and management information 1. Many diagnoses (such as hepatitis B or C infection) can be established through blood-based tests alone 2.
Common Pitfalls to Avoid
- Do not perform biopsy solely based on imaging or necrotic biopsy material, as solitary necrotic nodules can mimic metastases 3
- Never rely exclusively on typical HCC imaging patterns in non-cirrhotic patients; histologic confirmation is mandatory 3
- Ensure multiprofessional discussions (including histopathologists) occur before performing biopsies outside established guidelines or protocols, with documentation in medical notes 1
- All healthcare professionals involved in requesting, obtaining, and interpreting the biopsy must be aware of the specific indication(s) 1
- Consider mixed histiocytoses when evaluating solitary liver lesions dominated by histiocytes; additional biopsies of atypical sites may be necessary 3